Are you screening all adults for viral hepatitis, as recommended by the Centers for Disease Control and Prevention (CDC)? Join 2 experts in a discussion of best practices.
Credit available for this activity expires: 04/25/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000686?ecd=bdc_podcast_libsyn_mscpedu
Postexposure Prophylaxis for COVID-19 Prevention: Where Do We Stand?
Navigating the Management of Triple-Negative Breast Cancer: Immunotherapy Considerations
Expert Perspective Series: Tips for Addressing Patients FAQs About COVID-19 Vaccines
Expanding Targetable Treatment in Thyroid Cancer: NTRK Fusions
Diagnostic Pearls in EGIDs Beyond EoE
Evidence Update and Practical Perspectives: Monoclonal Antibodies for COVID-19 Treatment
Vaccines vs Monoclonal Antibodies for COVID-19: Complementary Approaches to Tackling the Pandemic
Expert Exchange: The Why, When, and How of "On-Demand" Therapies for Parkinson Disease
Bipolar Depression: Putting the Patient at the Center of Care
Year in Review: Perspectives on JAK Inhibitors for Atopic Dermatitis
Mirror, Mirror on the Wall: The Perception of Acne
Ask the Experts: What Practical Information Do I Need to Know About Cannabinoids?
Everything You Need to Know About ICIs in Gynecologic Cancers
The Role of Antibiotic Stewardship in the Management of Rosacea
Challenges and Opportunities in the Use of Monoclonal Antibody Therapy for COVID-19
Emerging Treatments for Diabetic Macular Edema: New Data
Neutralizing the Virus: A Focus on SARS-CoV-2–Specific Monoclonal Antibodies
Gene Testing for Limb-Girdle Muscular Dystrophy: What, When, How
Optimizing Access to Monoclonal Antibodies for COVID-19: US Perspective
Understanding the Potential of Antibodies for COVID-19
Create your
podcast in
minutes
It is Free
This Week in Cardiology
Medicine and the Machine
One-on-One with Eric Topol
Keeping Current
The Bob Harrington Show